Discover
SBFM
Sunshine Biopharma, Inc.
2.93
4 x 3.03
1 x 0.14
bid
ask
-
0.40
12.01%
3 @ 04:16 PM
2.84 -0.09 (3.07%)
| Ytd | -98.81% | |
| 1y | -99.16% |
2.65
day range
3.21
2.58
52 week range
464.00
| Open | 3.10 | Prev Close | 3.33 | Low | 2.65 | High | 3.21 | Mkt Cap | 2.23M |
| Vol | 111.27K | Avg Vol | 302.45K | EPS | -189.00 | P/E | N/A | Forward P/E | 0.02 |
| Beta | -1.04 | Short Ratio | 0.39 | Inst. Own | 1.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 14.57 | 200-d Avg | 110.27 | 1yr Est | 300.00 |
| Income Statement | |||
| Total Revenue | 9.26M | ||
| Revenues (USD) | 9.26M | ||
| Cost of Revenue | 6.84M | ||
| Gross Profit | 2.43M | ||
| Operating Expenses | 4.04M | ||
| Research and Development Expense | 13.22K | ||
| Selling, General and Administrative Expense | 3.81M | ||
| Operating Income | -1.61M | ||
| Net Income | -1.56M | ||
| Net Income Common Stock | -1.56M | ||
| Net Income Common Stock (USD) | -1.56M | ||
| Consolidated Income | -1.56M | ||
| Earnings per Basic Share | -23.00 | ||
| Earnings per Basic Share (USD) | -23.00 | ||
| Earnings per Diluted Share | -23.00 | ||
| Earning Before Interest & Taxes (EBIT) | -1.56M | ||
| Earning Before Interest & Taxes (USD) | -1.56M | ||
| Weighted Average Shares | 68.27K | ||
| Weighted Average Shares Diluted | 68.27K | ||
| Balance Sheet | |||
| Cash and Equivalents | 14.03M | ||
| Cash and Equivalents (USD) | 14.03M | ||
| Trade and Non-Trade Receivables | 4.04M | ||
| Current Assets | 30.67M | ||
| Property, Plant & Equipment Net | 1.13M | ||
| Total Assets | 33.63M | ||
| Debt Current | 202.52K | ||
| Total Debt | 678.34K | ||
| Current Liabilities | 5.62M | ||
| Debt Non-Current | 475.82K | ||
| Total Liabilities | 6.09M | ||
| Accumulated Retained Earnings (Deficit) | -77.82M | ||
| Accumulated Other Comprehensive Income | -658.93K | ||
| Shareholders Equity | 27.54M | ||
| Shareholders Equity (USD) | 27.54M | ||
| Assets Non-Current | 2.97M | ||
| Total Debt (USD) | 678.34K | ||
| Goodwill and Intangible Assets | 1.84M | ||
| Inventory | 12.12M | ||
| Liabilities Non-Current | 475.82K | ||
| Trade and Non-Trade Payables | 5.15M | ||
| Tax Liabilities | 268.28K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 77.97K | ||
| Net Cash Flow from Financing | 7.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.88M | ||
| Capital Expenditure | -7.01K | ||
| Issuance (Purchase) of Equity Shares | 5.09M | ||
| Net Cash Flow from Investing | -5.12K | ||
| Net Cash Flow from Operations | -917.98K | ||
| Effect of Exchange Rate Changes on Cash | -45.80K | ||
| Share Based Compensation | 96.90K | ||